🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

45+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 20 of 45 recruiting trials for “thiemann-disease-familial-form

RecruitingNCT07118137

Memory Deterioration in Alzheimer Disease

👨‍⚕️ Axel Sandvig Professor, MD PhD, Norwegian University of Science and Technology (NTNU)📍 1 site📅 Started Oct 2023View details ↗
NARecruitingNCT05820919

Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase

👨‍⚕️ Lynn Snow, PhD, The University of Alabama📍 3 sites📅 Started Sep 2023View details ↗
NARecruitingNCT05733520

I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms

👨‍⚕️ Richard J Holden, PhD, Indiana University📍 2 sites📅 Started May 2023View details ↗
RecruitingNCT06874231

Brain Connectivity Marker for Alzheimer's Disease

🏥 Karolinska Institutet📍 1 site📅 Started Apr 2023View details ↗
NARecruitingNCT06711952

German Validation Study of the Subjective Cognitive Decline Questionnaire (SCD-Q)

👨‍⚕️ Robert Perneczky, Prof. Dr., Klinik und Poliklinik für Psychiatrie und Psychotherapie des LMU Klinikums📍 1 site📅 Started Feb 2023View details ↗
Phase 1RecruitingNCT05464368

R21 Roche: 3-Way Tau Tracers in AD

👨‍⚕️ Dean F Wong, Head Researcher/Professor of Radiology📍 1 site📅 Started Feb 2023View details ↗
Phase 3RecruitingNCT05641688

[18F]PI-2620 Phase 3 Histopathological Study

👨‍⚕️ Alireza Atri, MD, PhD, Banner Health📍 25 sites📅 Started Dec 2022View details ↗
RecruitingNCT05614310

Detecting Early Alzheimer's Using MR

👨‍⚕️ Gordon Waiter, PhD, University of Aberdeen📍 1 site📅 Started Nov 2022View details ↗
RecruitingNCT06121544

The Swedish BioFINDER - Preclinical AD Study

🏥 Skane University Hospital📍 1 site📅 Started Apr 2022View details ↗
RecruitingNCT05322343

Biobank and Brain Health in Bordeaux.

👨‍⚕️ Cécilia SAMIERI, Dr, Bordeaux Population Health Researh Center Inserm📍 1 site📅 Started Mar 2022View details ↗
Phase 2RecruitingNCT04804241

Senicapoc in Alzheimer's Disease

👨‍⚕️ John Olichney, MD, University of California, Davis📍 2 sites📅 Started Mar 2022View details ↗
Enrolling by InvitationNCT04994847

APOE in the Predisposition to, Protection From, and Prevention of Alzheimer's Disease

🏥 Banner Health📍 1 site📅 Started May 2021View details ↗
RecruitingNCT05171725

Multidisciplinary Expert System for the Assessment & Management of Complex Brain Disorders

👨‍⚕️ Elissaios Karageorgiou, Neurological Institute of Athens📍 4 sites📅 Started Apr 2021View details ↗
Phase 2Enrolling by InvitationNCT04786223

Targeting Neuroinflammation as a Contributing Pathology in Alzheimer's Disease Dementia and Related Dementias

👨‍⚕️ Val Lowe, MD, Mayo Clinic📍 1 site📅 Started Mar 2021View details ↗
RecruitingNCT06534658

Study on Multimodal Imaging and Molecular Imaging Techniques in Degenerative Dementia

👨‍⚕️ Gang Wang, PhD. MD., RenJi Hospital📍 8 sites📅 Started Jul 2020View details ↗
RecruitingNCT04360200

Cognitive Impairment in Ageing People

🏥 Yamei Tang📍 1 site📅 Started Apr 2020View details ↗
Phase 2RecruitingNCT03875638

Treating Hyperexcitability in AD With Levetiracetam

🏥 Beth Israel Deaconess Medical Center📍 1 site📅 Started Aug 2019View details ↗
RecruitingNCT04239079

Autoimmune Features of Neurodegenerative Disorders

👨‍⚕️ Karen Marder, MD, MPH, Columbia University📍 1 site📅 Started May 2019View details ↗
RecruitingNCT05655650

Identifying Biomarkers in Alzheimer's Disease

🏥 Chinese University of Hong Kong📍 1 site📅 Started Sep 2018View details ↗
Phase 2RecruitingNCT07496918

Brain Effects of Gamma Frequency Sensory Stimulation (40Hz Light, Sound and Other Devices)

👨‍⚕️ Ana Trisini Lipsanopoulos, BS, Massachusetts Institute of Technology📍 1 site📅 Started Feb 2018View details ↗
← PreviousPage 2 of 3Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →